You are on page 1of 1

23264 Federal Register / Vol. 66, No.

89 / Tuesday, May 8, 2001 / Notices

response to Program Announcement: RFA information collection is available on DEPARTMENT OF HEALTH AND
OH–01–008. the Internet at http://www.fda.gov/ HUMAN SERVICES
Contact Person for More Information: ohrms/dockets.
Pervis C. Major, PhD., Scientific Review Food and Drug Administration
Administrator, National Institute for Dated: May 2, 2001.
Occupational Safety and Health, CDC, 1095 William K. Hubbard, [Docket No. 00N–1637]
Willowdale Road, M/S B228, Morgantown,
Senior Associate Commissioner for Policy,
West Virginia 26505, telephone 304–285– Agency Information Collection
Planning, and Legislation.
5979. Activities; Submission for OMB
The Director, Management Analysis and [FR Doc. 01–11451 Filed 5–7–01; 8:45 am]
Review; Comment Request;
Services Office has been delegated the BILLING CODE 4160–01–S Transmittal of Advertising and
authority to sign Federal Register notices Promotional Labeling for Drugs and
pertaining to announcements of meetings and
Biologics for Human Use
other committee management activities, for DEPARTMENT OF HEALTH AND
both the Centers for Disease Control and HUMAN SERVICES AGENCY: Food and Drug Administration,
Prevention and the Agency for Toxic HHS.
Substances and Disease Registry. Food and Drug Administration ACTION: Notice.
Dated: April 20, 2001.
John C. Burckhardt, [Docket No. 96N–0393] SUMMARY: The Food and Drug
Acting Director, Management Analysis and Administration (FDA) is announcing
Services Office, Centers for Disease Control Agency Information Collection that the proposed collection of
and Prevention (CDC). Activities; Announcement of OMB information listed below has been
[FR Doc. 01–11509 Filed 5–7–01; 8:45 am] Approval; MedWatch: The FDA Medical submitted to the Office of Management
BILLING CODE 4163–19–P Products Reporting Program and Budget (OMB) for review and
clearance under the Paperwork
AGENCY: Food and Drug Administration, Reduction Act of 1995.
DEPARTMENT OF HEALTH AND HHS. DATES: Submit written comments on the
HUMAN SERVICES collection of information by June 7,
ACTION: Notice.
2001.
Food and Drug Administration
SUMMARY: The Food and Drug ADDRESSES: Submit written comments
[Docket No. 00N–1599] on the collection of information to the
Administration (FDA) is announcing
that a collection of information entitled Office of Information and Regulatory
Agency Information Collection Affairs, OMB, New Executive Office
Activities; Announcement of OMB ‘‘MedWatch: The FDA Medical Products
Reporting Program’’ has been approved Bldg., 725 17th St. NW., rm. 10235,
Approval; Use of Impact-Resistant Washington, DC 20503, Attn: Wendy
Lenses in Eyeglasses and Sunglasses by the Office of Management and
Budget (OMB) under the Paperwork Taylor, Desk Officer for FDA.
AGENCY: Food and Drug Administration, Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT:
HHS. Karen L. Nelson, Office of Information
FOR FURTHER INFORMATION CONTACT: Resources Management (HFA–250),
ACTION: Notice.
Mark L. Pincus, Office of Information Food and Drug Administration, 5600
SUMMARY: The Food and Drug Resources Management (HFA–250), Fishers Lane, Rockville, MD 20857,
Administration (FDA) is announcing Food and Drug Administration, 5600 301–827–1482.
that a collection of information entitled Fishers Lane, Rockville, MD 20857,
SUPPLEMENTARY INFORMATION: In
‘‘Use of Impact-Resistant Lenses in 301–827–1471.
compliance with 44 U.S.C. 3507, FDA
Eyeglasses and Sunglasses’’ has been SUPPLEMENTARY INFORMATION: In the has submitted the following proposed
approved by the Office of Management Federal Register of November 16, 2000 collection of information to OMB for
and Budget (OMB) under the Paperwork (65 FR 69314), the agency announced review and clearance.
Reduction Act of 1995. that the proposed information collection
FOR FURTHER INFORMATION CONTACT: Transmittal of Advertising and
had been submitted to OMB for review
Peggy Schlosburg, Office of Information Promotional Labeling for Drugs and
and clearance under 44 U.S.C. 3507. An
Resources Management (HFA–250), Biologics for Human Use
agency may not conduct or sponsor, and
Food and Drug Administration, 5600 a person is not required to respond to, Under § 314.81(b)(3)(i) (21 CFR
Fishers Lane, Rockville, MD 20857, a collection of information unless it 314.81(b)(3)(i), sponsors of approved
301–827–1223. displays a currently valid OMB control applications for marketed prescription
SUPPLEMENTARY INFORMATION: In the number. OMB has now approved the drugs and antibiotic drugs for human
Federal Register of March 7, 2001 (66 information collection and has assigned use are required to submit specimens of
FR 13769), the agency announced that OMB control number 0910–0291. The promotional labeling and
the proposed information collection had approval expires on April 30, 2003. A advertisements at the time of initial
been submitted to OMB for review and copy of the supporting statement for this dissemination of the labeling and at the
clearance under 44 U.S.C. 3507. An information collection is available on time of initial publication of the
agency may not conduct or sponsor, and the Internet at http://www.fda.gov/ advertisements. Each submission is
a person is not required to respond to, ohrms/dockets. required to be accompanied by a
a collection of information unless it completed transmittal Form FDA 2253
Dated: May 2, 2001.
displays a currently valid OMB control (Transmittal of Advertisements and
number. OMB has now approved the William K. Hubbard, Promotional Labeling for Drugs and
information collection and has assigned Senior Associate Commissioner for Policy, Biologics for Human Use). Statutory
OMB control number 0910–0182. The Planning, and Legislation. authority for the collection of this
approval expires on April 30, 2004. A [FR Doc. 01–11453 Filed 5–7–01; 8:45 am] information is provided by sections
copy of the supporting statement for this BILLING CODE 4160–01–S 505(a), (b), (j), and (k) and 701(a) of the

VerDate 11<MAY>2000 12:10 May 07, 2001 Jkt 194001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\08MYN1.SGM pfrm04 PsN: 08MYN1